US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exicure, Inc.

11.32

+0.18001.62%

Volume:5.05K

Turnover:57.36K

Market Cap:71.52M

PE:-2.38

High:11.60

Open:11.44

Low:11.32

Close:11.14

Loading ...

Overview Company News Filings

Exicure Inc. Announces Convertible Bond Redemption with KC Creation Co., Ltd

Exicure completes patient enrollment in GPC-100 trial

Exicure Completes Patient Enrollment in Phase 2 Study of Gpc-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

THOMSON REUTERS

Exicure Inc: Topline Results Expected H2 2025

THOMSON REUTERS

Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

Exicure Close to Finishing Patient Recruitment in Phase 2 Study of GPC-100 in Multiple Myeloma

MT Newswires Live

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

Exicure, Inc. (Nasdaq: Xcur) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (Aml)

THOMSON REUTERS

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

Exicure FY24 EPS $(4.75) Up From $(10.55) YoY; Revenue $500K

Exicure Inc - Cash May Not Be Sufficient to Fund Operations; Doubts Ability to Continue as Going Concern

THOMSON REUTERS

Press Release: Exicure, Inc. Reports Full Year 2024 Financial Results

Exicure Gets Patent in Australia for Potential Cancer Treatment Combination

MT Newswires Live

Exicure, Inc. Announces Issuance of New Patent in Australia

THOMSON REUTERS

Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia

Top Premarket Gainers

MT Newswires Live

Exicure Acquires GPCR's California Subsidiary, Enters Into Licensing Agreement

MT Newswires Live

BRIEF-Exicure, Inc. Announces Purchase Agreement With Gpcr Therapeutics Inc.

Exicure announces purchase agreement with GPCR Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/XCUR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XCUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XCUR\",,,,,undefined,":{"symbol":"XCUR","market":"US","secType":"STK","nameCN":"Exicure, Inc.","latestPrice":11.32,"timestamp":1747066618130,"preClose":11.14,"halted":0,"volume":5047,"delay":0,"floatShares":4589700,"shares":6317771,"eps":-4.747763,"marketStatus":"Trading","change":0.18,"latestTime":"05-12 12:22:32 EDT","open":11.44,"high":11.6,"low":11.32,"amount":57358.963214,"amplitude":0.025135,"askPrice":11.92,"askSize":9,"bidPrice":11.01,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-4.747763,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747080000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":11.14,"postHourTrading":{"tag":"盘后","latestPrice":11.44,"preClose":11.44,"latestTime":"19:57 EDT","volume":196,"amount":2157.23,"timestamp":1746835039340},"volumeRatio":0.380953},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XCUR\",,,,,undefined,":{"symbol":"XCUR","floatShares":4589700,"roa":"-23.23%","roe":"-197.92%","lyrEps":-4.747763,"volumeRatio":0.380953,"shares":6317771,"dividePrice":0,"high":11.6,"amplitude":0.025135,"preClose":11.14,"low":11.32,"week52Low":1.44,"pbRate":"10.56","psRate":"143.03","week52High":36,"institutionHeld":0,"latestPrice":11.32,"committee":-0.5,"eps":-4.747763,"divideRate":0,"volume":5047,"delay":0,"ttmEps":-4.747763,"open":11.44,"prevYearClose":13.67,"prevWeekClose":11.44,"prevMonthClose":10.45,"prevQuarterClose":13.34,"fiveDayClose":10.73,"twentyDayClose":11.58,"sixtyDayClose":10.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XCUR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533139695","title":"Exicure Inc. Announces Convertible Bond Redemption with KC Creation Co., Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2533139695","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533139695?lang=en_us&edition=fundamental","pubTime":"2025-05-07 05:44","pubTimestamp":1746567896,"startTime":"0","endTime":"0","summary":"Exicure Inc. has entered into a convertible bond agreement with its South Korean subsidiary, KC Creation Co., Ltd., involving a subscription amount of approximately $3.125 million USD. The bonds, maturing on April 30, 2028, offer a yield to maturity of 2.9% per annum. Exicure holds a put option allowing for redemption of the bonds in part or in full starting one year after the issuance date and every three months thereafter until maturity. Conversion rights, allowing Exicure to convert the bonds into common stock of KC Creation at a specified price per share, can be exercised between April 30, 2026, and March 31, 2028. The funds are intended for acquiring stocks of other corporations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nNDL80pMQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2533558754","title":"Exicure completes patient enrollment in GPC-100 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533558754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533558754?lang=en_us&edition=fundamental","pubTime":"2025-05-05 21:26","pubTimestamp":1746451564,"startTime":"0","endTime":"0","summary":"Exicure (XCUR) announced it has completed patient enrollment in its ongoing Phase 2 clinical trial evaluating the safety and efficacy of GPC-100 in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exicure-completes-patient-enrollment-in-gpc-100-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exicure-completes-patient-enrollment-in-gpc-100-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443978.SGD","BK4159","LU2237443549.SGD","LU2237443622.USD","XCUR","BK4139","BK4585","BK4588","LU2237443382.USD","GPC"],"gpt_icon":0},{"id":"2533899586","title":"Exicure Completes Patient Enrollment in Phase 2 Study of Gpc-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant","url":"https://stock-news.laohu8.com/highlight/detail?id=2533899586","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533899586?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA1QLVJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2533586972","title":"Exicure Inc: Topline Results Expected H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586972?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA1QLVJW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2533358983","title":"Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant","url":"https://stock-news.laohu8.com/highlight/detail?id=2533358983","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533358983?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446400,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., May 05, 2025----Exicure, Inc. , a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed patient enrollment in its ongoing Phase 2 clinical trial  evaluating the safety and efficacy of GPC-100  in combination with propranolol and G-CSF in multiple myeloma patients undergoing autologous stem cell transplant .GPC-100  is a highly selective small molecule antagonist of CXCR4, a chemokine receptor that plays a central role in retaining hematopoietic stem cells in the bone marrow niche. By blocking CXCR4, GPC-100 may enhance the mobilization of these cells into the peripheral blood for collection and use in autologous stem cell transplant  procedures. Originally developed by GPCR Therapeutics, Inc., GPC-100 became part of Exicure’s pipeline following the company’s acquisition in January 2025. In addition to multiple myeloma, GPC-100 is also being considered in acute myeloid leukemia  and other diseases wh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exicure-completes-patient-enrollment-phase-120000654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2237443382.USD","GPC","BK4588","LU2237443549.SGD","XCUR","BK4159","BK4585","LU2237443978.SGD","LU2237443622.USD"],"gpt_icon":0},{"id":"2527463407","title":"Exicure Close to Finishing Patient Recruitment in Phase 2 Study of GPC-100 in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2527463407","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527463407?lang=en_us&edition=fundamental","pubTime":"2025-04-15 16:53","pubTimestamp":1744707182,"startTime":"0","endTime":"0","summary":"Exicure  said its subsidiary, GPCR Therapeutics USA, dosed the 19th patient in an ongoing phase 2 clinical trial of a small molecule inhibitor in multiple myeloma patients undergoing autologous stem cell transplant.The trial is expected to finish patient recruitment at the end of April.The study is a multi-center trial evaluating the safety and efficacy of the CXCR4 inhibitor, GPC-100 , and propranolol in combination with G-CSF, the company said late Monday.It said the study's preliminary results are encouraging as 100% of patients achieved the primary endpoint of successful stem cell mobilization.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GPC","BK4585","BK4139","XCUR","BK4588","LU2237443382.USD","LU2237443549.SGD","LU2237443978.SGD","BK4159","LU2237443622.USD"],"gpt_icon":0},{"id":"2527121159","title":"Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2527121159","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527121159?lang=en_us&edition=fundamental","pubTime":"2025-04-15 06:11","pubTimestamp":1744668660,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., April 14, 2025----Exicure, Inc.  today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 , a small molecule CXCR4 inhibitor, for the mobilization of stem cells in multiple myeloma  patients undergoing autologous stem cell transplant  .The study is an open-label, multi-center trial evaluating the safety and efficacy of GPC-100 and propranolol in combination with G-CSF. Data from an interim analysis of 10 patients were previously presented at the 2024 American Society of Hematology  Annual Meeting.Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value. For further information, see www.exicuret","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exicure-inc-nasdaq-xcur-nears-221100339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237443549.SGD","USJW.SI","IE00B64PRP62.GBP","SQQQ","BK4585","BK4112","TQQQ","BK4109","IE00BGHQF748.EUR","IE00BKPKM429.USD","GPC","LU2095319765.USD","TSYW.SI","MNQmain","NVIW.SI","BK4588","NQmain","QID","LU2237443978.SGD","LU2210150020.SGD","NDAQ","QLD","USAW.SI","LU2237443382.USD",".IXIC","LU2237443622.USD","BK4159","LU2210149790.SGD","LU2463526074.USD","IE00B3QW5Z07.USD","ASH","PSQ","XCUR","BK4139"],"gpt_icon":1},{"id":"2526263916","title":"Exicure, Inc. (Nasdaq: Xcur) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (Aml)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526263916","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526263916?lang=en_us&edition=fundamental","pubTime":"2025-04-12 07:42","pubTimestamp":1744414920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nTUA7LLXFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2526626343","title":"Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526626343","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526626343?lang=en_us&edition=fundamental","pubTime":"2025-04-12 07:42","pubTimestamp":1744414920,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., April 11, 2025----Exicure, Inc.  today shared updates on its lead asset, GPC-100 , a small molecule CXCR4 inhibitor.In addition to AML, GPC-100 is currently being evaluated in an ongoing Phase 2 trial in patients with multiple myeloma  undergoing autologous stem cell transplant . Clinical trial results for this study are expected in Q4 2025.Current Evaluating Potential Indication Expansions – In addition to AML and MM, Exicure is evaluating a range of potential indications for GPC-100, including sickle cell disease, pediatric oncology, and cell and gene therapy settings.Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value. For further information, see www.exicuretx.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exicure-inc-nasdaq-xcur-announces-234200798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","LU2095319765.USD","SQQQ","QLD","USAW.SI","USJW.SI","TSYW.SI","XCUR","NQmain","IE00BKPKM429.USD","IE00B64PRP62.GBP","TQQQ","LU2210149790.SGD","LU2210150020.SGD","BK4112","BK4588","QID","NVIW.SI",".IXIC","BK4585","BK4139","IE00BGHQF748.EUR","NDAQ","PSQ","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2520319199","title":"Exicure FY24 EPS $(4.75) Up From $(10.55) YoY; Revenue $500K","url":"https://stock-news.laohu8.com/highlight/detail?id=2520319199","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520319199?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:04","pubTimestamp":1742328298,"startTime":"0","endTime":"0","summary":"Exicure FY24 EPS $(4.75) Up From $(10.55) YoY; Revenue $500K","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44384714/exicure-fy24-eps-4-75-up-from-10-55-yoy-revenue-500k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Exicure FY24 EPS $(4.75) Up From $(10.55) YoY; Revenue $500K","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR"],"gpt_icon":0},{"id":"2520313139","title":"Exicure Inc - Cash May Not Be Sufficient to Fund Operations; Doubts Ability to Continue as Going Concern","url":"https://stock-news.laohu8.com/highlight/detail?id=2520313139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520313139?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:01","pubTimestamp":1742328060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA1RKN02:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2520931393","title":"Press Release: Exicure, Inc. Reports Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520931393","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520931393?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:01","pubTimestamp":1742328060,"startTime":"0","endTime":"0","summary":"Exicure, Inc.  has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that the Company was exploring strategic alternatives to maximize stockholder value. We continue to engage in a broader exploration of strategic alternatives. This effort involves exploring growth through transactions with potential partners that see opportunity in joining an existing, publicly-traded organization.Cash Position: Cash and cash equivalents were $12.5 million as of December 31, 2024, as compared to $0.8 million as of December 31, 2023. Our current liquidity may not be sufficient to fund operations for the next 12 months. Additional financing will be needed to fund our ongoing operations and exploration of strategic alternatives and pursue any a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2519826680","title":"Exicure Gets Patent in Australia for Potential Cancer Treatment Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2519826680","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519826680?lang=en_us&edition=fundamental","pubTime":"2025-03-14 16:20","pubTimestamp":1741940413,"startTime":"0","endTime":"0","summary":"Exicure  said late Thursday it received a patent in Australia covering its combination approach to cancer treatment, specifically targeting CXCR4 and GPCRx.The patent supports the company's ongoing phase 2 clinical trial assessing the combination of GPC-100 and propranolol to treat multiple myeloma, a cancer of plasma cells.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","XKO.AU","XAO.AU","XCUR","XJO.AU"],"gpt_icon":0},{"id":"2519864583","title":"Exicure, Inc. Announces Issuance of New Patent in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2519864583","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519864583?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:45","pubTimestamp":1741898701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW0U6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2519861560","title":"Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2519861560","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519861560?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:08","pubTimestamp":1741896480,"startTime":"0","endTime":"0","summary":"CHICAGO, March 13, 2025----Exicure, Inc.  today announced that the Australian Patent Office has issued Patent No. 2018388302, titled \"GPCR Heteromer Inhibitors and Uses Thereof.\" This patent covers the company’s innovative combination approach to cancer treatment, specifically targeting CXCR4 and GPCRx.The newly granted patent supports Exicure’s ongoing Phase 2 clinical trial , which evaluates the combination of GPC-100 and propranolol in multiple myeloma patients. This method aims to improve hematopoietic stem cell mobilization by co-targeting CXCR4 and ADRB2, thereby enhancing the efficacy of CXCR4 inhibitors like GPC-100.\"This issuance reinforces the exclusivity of our lead clinical program,\" said Andy Yoo, CEO of Exicure, Inc. \"By co-targeting CXCR4 and ADRB2, we can significantly enhance the potency of CXCR4 inhibitors like GPC-100. This opens new possibilities for these inhibitors to become more effective therapies, and our well-devised patent portfolio ensures strong intellectua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exicure-inc-nasdaq-xcur-announces-200800965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","LU2095319765.USD","LU2210150020.SGD",".IXIC","MNQmain","BK4139","QID","NDAQ","BK4585","QLD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","TQQQ","BK4112","IE00B64PRP62.GBP","TSYW.SI","LU2210149790.SGD","USAW.SI","SQQQ","XCUR","PSQ","NQmain","IE00BGHQF748.EUR","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2516739966","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2516739966","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516739966?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:36","pubTimestamp":1741091764,"startTime":"0","endTime":"0","summary":"Exicure (XCUR) shares surged 14% pre-bell Tuesday, extending Monday's rally.RxSight (RXST) shares advanced 15% following a 5% drop in the previous session.Okta (OKTA) shares increased 14%, a day after","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0516422366.SGD","BK4528","LU0345775950.USD","BK4198","BK4581","LU0048573645.USD","BK4566","LU0499858602.USD","BK4585","LU2045819591.USD","BK4503","LU0345776255.USD","SG9999002406.SGD","SG9999005177.SGD","SG9999013460.SGD","XCUR","OKTA","LU0737861269.HKD","LU0210637038.USD","LU0979878070.USD","SG9999002414.USD","LU0251143029.SGD","LU0516423174.USD","SG9999006266.SGD","LU0516422440.USD","LU1242518857.USD","SG9999013486.USD","BK4139","BK4539","LU2125910500.SGD","SG9999002679.SGD","BK4560","LU2286300806.USD","RXST","LU0499858438.USD","ASTH","SE","SG9999002620.SGD","LU1242518931.SGD","SGXZ58947870.SGD","BK4535","IE0034224299.USD","LU0532188223.SGD","BK4551","BK4588","BK4548","BK4116","LU0516422952.EUR","SG9999002604.SGD","LU1770036033.HKD"],"gpt_icon":1},{"id":"2505402066","title":"Exicure Acquires GPCR's California Subsidiary, Enters Into Licensing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2505402066","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505402066?lang=en_us&edition=fundamental","pubTime":"2025-01-23 16:52","pubTimestamp":1737622351,"startTime":"0","endTime":"0","summary":"Exicure  said late Wednesday it has agreed to acquire all shares of GPCR Therapeutics USA, a subsidiary of GPCR Therapeutics, a Korean corporation.In connection with the deal, Exicure and GPCR made a licensing and collaboration agreement to further develop and commercialize certain GPCR technologies, the company said.Financial terms were not disclosed.Under the agreement, Exicure is to pay GPCR milestone payments upon reaching specific milestone events relating to clinical trials, marketing authorizations, and net sales, as well as a recurring royalty payment based on at least 10% of net sales, the company said.Shares of Exicure were up more than 46% in Wednesday's after-hours activity.Price: 15.21, Change: +4.84, Percent Change: +46.67","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","BK4599","GPCR","XCUR"],"gpt_icon":1},{"id":"2505701720","title":"BRIEF-Exicure, Inc. Announces Purchase Agreement With Gpcr Therapeutics Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2505701720","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505701720?lang=en_us&edition=fundamental","pubTime":"2025-01-23 05:53","pubTimestamp":1737582837,"startTime":"0","endTime":"0","summary":"BRIEF-Exicure, Inc. Announces Purchase Agreement With Gpcr Therapeutics Inc.Exicure Inc XCUR.O:EXICURE, INC. ANNOUNCES PURCHASE AGREEMENT WITH GPCR THERAPEUTICS INC.EXICURE INC: ACQUIRED FROM GPCR ALL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250122:nTUA5GH44K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2505706822","title":"Exicure announces purchase agreement with GPCR Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2505706822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505706822?lang=en_us&edition=fundamental","pubTime":"2025-01-23 05:05","pubTimestamp":1737579939,"startTime":"0","endTime":"0","summary":"Exicure (XCUR) “announced that on January 19, 2025, Exicure Inc. entered into a Share Purchase Agreement with GPCR Therapeutics Inc., a Korean corp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exicure-announces-purchase-agreement-with-gpcr-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exicure-announces-purchase-agreement-with-gpcr-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XCUR","BK4007","GPCR","BK4599","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XCUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-18","symbol":"XCUR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"post","actualEps":-3.39},{"market":"US","date":"2024-11-14","symbol":"XCUR","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2024-08-28","symbol":"XCUR","defaultRemindTime":1724851800000,"type":"split","dateTimestamp":1724817600000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-08-13","symbol":"XCUR","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-06-17","symbol":"XCUR","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1718596800000,"reportTimeType":"post","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XCUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XCUR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XCUR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XCUR","date":"2025-05-09","current":-7.411219,"percent":0.215272,"low":-19.17664,"twenty":-7.694683,"median":-0.597786,"eighty":-0.130651,"high":8.65467,"avg":-2.864528,"sd":4.407951,"marketCap":71896233},"quantilePoints":[{"date":"2020-05-15","current":-10.659662,"twenty":-11.139762,"median":-8.705265,"eighty":-5.620299,"marketCap":211775511},{"date":"2020-05-22","current":-12.151138,"twenty":-11.139762,"median":-8.712543,"eighty":-5.635099,"marketCap":241406655},{"date":"2020-05-29","current":-12.151138,"twenty":-11.176862,"median":-8.813447,"eighty":-5.6387,"marketCap":241406655},{"date":"2020-06-05","current":-12.984609,"twenty":-11.25116,"median":-8.831401,"eighty":-5.65255,"marketCap":257965232},{"date":"2020-06-12","current":-12.063404,"twenty":-11.331521,"median":-8.860213,"eighty":-5.671928,"marketCap":239663645},{"date":"2020-06-19","current":-13.072343,"twenty":-11.380101,"median":-8.864968,"eighty":-5.686363,"marketCap":259708241},{"date":"2020-06-26","current":-11.756335,"twenty":-11.390221,"median":-8.897131,"eighty":-5.695803,"marketCap":233563116},{"date":"2020-07-02","current":-10.878997,"twenty":-11.380101,"median":-8.90578,"eighty":-5.698687,"marketCap":216133033},{"date":"2020-07-10","current":-10.440328,"twenty":-11.380101,"median":-8.924819,"eighty":-5.698687,"marketCap":207417991},{"date":"2020-07-17","current":-10.571929,"twenty":-11.380101,"median":-8.989424,"eighty":-5.706685,"marketCap":210032504},{"date":"2020-07-24","current":-10.133259,"twenty":-11.380101,"median":-9.033549,"eighty":-5.71907,"marketCap":201317462},{"date":"2020-07-31","current":-9.826191,"twenty":-11.372674,"median":-9.086059,"eighty":-5.727263,"marketCap":195216933},{"date":"2020-08-07","current":-10.528062,"twenty":-11.357841,"median":-9.118636,"eighty":-5.739594,"marketCap":209161001},{"date":"2020-08-14","current":-10.582641,"twenty":-11.352304,"median":-9.192471,"eighty":-5.748051,"marketCap":200625704},{"date":"2020-08-21","current":-9.754434,"twenty":-11.338449,"median":-9.272478,"eighty":-5.758673,"marketCap":184924560},{"date":"2020-08-28","current":-9.731428,"twenty":-11.300119,"median":-9.303224,"eighty":-5.758673,"marketCap":184488418},{"date":"2020-09-04","current":-8.69617,"twenty":-11.272968,"median":-9.275351,"eighty":-5.766671,"marketCap":164861990},{"date":"2020-09-11","current":-8.420101,"twenty":-11.271504,"median":-9.235975,"eighty":-5.782667,"marketCap":159628275},{"date":"2020-09-18","current":-9.432354,"twenty":-11.266738,"median":-9.248308,"eighty":-5.798664,"marketCap":178818561},{"date":"2020-09-25","current":-8.052009,"twenty":-11.25116,"median":-9.21093,"eighty":-5.811849,"marketCap":152649991},{"date":"2020-10-02","current":-7.683917,"twenty":-11.250809,"median":-9.156285,"eighty":-5.867578,"marketCap":145671706},{"date":"2020-10-09","current":-8.788193,"twenty":-11.24886,"median":-9.118636,"eighty":-5.880853,"marketCap":166606562},{"date":"2020-10-16","current":-9.110273,"twenty":-11.241333,"median":-9.110273,"eighty":-5.886089,"marketCap":172712561},{"date":"2020-10-23","current":-7.683917,"twenty":-11.205599,"median":-9.062072,"eighty":-5.886089,"marketCap":145671706},{"date":"2020-10-30","current":-6.901722,"twenty":-11.146452,"median":-9.01825,"eighty":-5.886089,"marketCap":130842850},{"date":"2020-11-06","current":-7.13178,"twenty":-11.139762,"median":-9.003401,"eighty":-5.886089,"marketCap":135204277},{"date":"2020-11-13","current":-6.830866,"twenty":-11.139762,"median":-8.934048,"eighty":-5.886089,"marketCap":150033133},{"date":"2020-11-20","current":-5.758579,"twenty":-11.139762,"median":-8.920908,"eighty":-5.886089,"marketCap":126481421},{"date":"2020-11-27","current":-6.354294,"twenty":-11.139762,"median":-8.909313,"eighty":-5.886089,"marketCap":139565707},{"date":"2020-12-04","current":-5.996865,"twenty":-11.139762,"median":-8.897131,"eighty":-5.879544,"marketCap":131715135},{"date":"2020-12-11","current":-6.473437,"twenty":-11.139762,"median":-8.869724,"eighty":-5.879544,"marketCap":142182561},{"date":"2020-12-18","current":-7.903153,"twenty":-11.139762,"median":-8.860213,"eighty":-5.886089,"marketCap":173584846},{"date":"2020-12-24","current":-7.697375,"twenty":-11.121939,"median":-8.860213,"eighty":-5.886089,"marketCap":169065155},{"date":"2020-12-31","current":-7.059251,"twenty":-11.117483,"median":-8.833668,"eighty":-5.886089,"marketCap":155049393},{"date":"2021-01-08","current":-7.976555,"twenty":-11.105992,"median":-8.816512,"eighty":-5.886089,"marketCap":175197055},{"date":"2021-01-15","current":-9.212921,"twenty":-11.083087,"median":-8.833668,"eighty":-5.886089,"marketCap":202352597},{"date":"2021-01-22","current":-9.292686,"twenty":-11.072288,"median":-8.860213,"eighty":-5.886089,"marketCap":204104566},{"date":"2021-01-29","current":-8.495031,"twenty":-11.070452,"median":-8.84409,"eighty":-5.894497,"marketCap":186584861},{"date":"2021-02-05","current":-9.292686,"twenty":-11.04391,"median":-8.860213,"eighty":-5.91124,"marketCap":204104566},{"date":"2021-02-12","current":-10.848115,"twenty":-11.04391,"median":-8.860213,"eighty":-5.933322,"marketCap":238267993},{"date":"2021-02-19","current":-10.050459,"twenty":-11.004271,"median":-8.869724,"eighty":-5.963959,"marketCap":220748287},{"date":"2021-02-26","current":-8.654562,"twenty":-10.995346,"median":-8.880216,"eighty":-5.992331,"marketCap":190088804},{"date":"2021-03-05","current":-8.215852,"twenty":-10.987291,"median":-8.87497,"eighty":-5.996865,"marketCap":180452964},{"date":"2021-03-12","current":-8.736125,"twenty":-10.978784,"median":-8.869724,"eighty":-5.996865,"marketCap":215502728},{"date":"2021-03-19","current":-8.736125,"twenty":-10.951154,"median":-8.869724,"eighty":-5.999936,"marketCap":215502728},{"date":"2021-03-26","current":-7.809026,"twenty":-10.886878,"median":-8.860213,"eighty":-6.020628,"marketCap":192633050},{"date":"2021-04-01","current":-7.987314,"twenty":-10.878997,"median":-8.860213,"eighty":-6.054263,"marketCap":197031066},{"date":"2021-04-09","current":-7.238503,"twenty":-10.878997,"median":-8.84409,"eighty":-6.063387,"marketCap":178559402},{"date":"2021-04-16","current":-6.418377,"twenty":-10.862276,"median":-8.829133,"eighty":-6.075284,"marketCap":158328536},{"date":"2021-04-23","current":-6.420807,"twenty":-10.848115,"median":-8.80082,"eighty":-6.063387,"marketCap":158388476},{"date":"2021-04-30","current":-7.027217,"twenty":-10.791263,"median":-8.788193,"eighty":-6.064096,"marketCap":173347387},{"date":"2021-05-07","current":-6.456478,"twenty":-10.791263,"median":-8.758197,"eighty":-6.075284,"marketCap":159268411},{"date":"2021-05-14","current":-3.412208,"twenty":-10.780681,"median":-8.736125,"eighty":-6.063387,"marketCap":130670491},{"date":"2021-05-21","current":-3.722408,"twenty":-10.780605,"median":-8.712543,"eighty":-5.996865,"marketCap":142549626},{"date":"2021-05-28","current":-3.837298,"twenty":-10.766687,"median":-8.697988,"eighty":-5.95715,"marketCap":146949308},{"date":"2021-06-04","current":-3.837298,"twenty":-10.745153,"median":-8.69617,"eighty":-5.902906,"marketCap":146949308},{"date":"2021-06-11","current":-3.860275,"twenty":-10.738939,"median":-8.675625,"eighty":-5.886089,"marketCap":147829243},{"date":"2021-06-18","current":-3.81432,"twenty":-10.738731,"median":-8.654562,"eighty":-5.875095,"marketCap":146069370},{"date":"2021-06-25","current":-3.584541,"twenty":-10.710569,"median":-8.578855,"eighty":-5.798664,"marketCap":137270010},{"date":"2021-07-02","current":-3.515608,"twenty":-10.691573,"median":-8.558135,"eighty":-5.758673,"marketCap":134630202},{"date":"2021-07-09","current":-3.584541,"twenty":-10.685216,"median":-8.527955,"eighty":-5.751535,"marketCap":137270010},{"date":"2021-07-16","current":-3.216896,"twenty":-10.668985,"median":-8.512124,"eighty":-5.718791,"marketCap":123191037},{"date":"2021-07-23","current":-3.28583,"twenty":-10.653085,"median":-8.482115,"eighty":-5.695803,"marketCap":125830842},{"date":"2021-07-30","current":-3.102007,"twenty":-10.638834,"median":-8.417202,"eighty":-5.65255,"marketCap":118791355},{"date":"2021-08-06","current":-3.010096,"twenty":-10.602487,"median":-8.408698,"eighty":-5.611111,"marketCap":115271612},{"date":"2021-08-13","current":-2.172904,"twenty":-10.582641,"median":-8.377834,"eighty":-5.59871,"marketCap":104849146},{"date":"2021-08-20","current":-2.099865,"twenty":-10.578913,"median":-8.366655,"eighty":-5.59871,"marketCap":101324805},{"date":"2021-08-27","current":-2.501579,"twenty":-10.576427,"median":-8.282317,"eighty":-5.59871,"marketCap":120708683},{"date":"2021-09-03","current":-2.556358,"twenty":-10.576427,"median":-8.215852,"eighty":-5.558719,"marketCap":123351939},{"date":"2021-09-10","current":-2.483319,"twenty":-10.574628,"median":-8.190044,"eighty":-5.539847,"marketCap":119827595},{"date":"2021-09-17","current":-2.574618,"twenty":-10.557394,"median":-8.155102,"eighty":-5.507564,"marketCap":124233023},{"date":"2021-09-24","current":-2.355501,"twenty":-10.532579,"median":-8.096203,"eighty":-5.442576,"marketCap":113659999},{"date":"2021-10-01","current":-2.118125,"twenty":-10.528062,"median":-8.073148,"eighty":-5.380537,"marketCap":102205890},{"date":"2021-10-08","current":-2.337241,"twenty":-10.525438,"median":-8.051328,"eighty":-5.295997,"marketCap":112778914},{"date":"2021-10-15","current":-2.154644,"twenty":-10.510804,"median":-8.003782,"eighty":-5.250314,"marketCap":103968061},{"date":"2021-10-22","current":-2.099865,"twenty":-10.494756,"median":-7.987314,"eighty":-5.201314,"marketCap":101324805},{"date":"2021-10-29","current":-2.063346,"twenty":-10.493101,"median":-7.975373,"eighty":-5.106823,"marketCap":99562634},{"date":"2021-11-05","current":-2.026827,"twenty":-10.490618,"median":-7.959986,"eighty":-4.998848,"marketCap":97800465},{"date":"2021-11-12","current":-2.008567,"twenty":-10.488049,"median":-7.912549,"eighty":-4.930438,"marketCap":96919380},{"date":"2021-11-19","current":-0.643811,"twenty":-10.478588,"median":-7.896789,"eighty":-4.898699,"marketCap":40535633},{"date":"2021-11-26","current":-0.693636,"twenty":-10.466,"median":-7.883154,"eighty":-4.801341,"marketCap":43672739},{"date":"2021-12-03","current":-0.594406,"twenty":-10.448351,"median":-7.838498,"eighty":-4.687409,"marketCap":37424964},{"date":"2021-12-10","current":-0.637233,"twenty":-10.44375,"median":-7.778046,"eighty":-4.650929,"marketCap":40121465},{"date":"2021-12-17","current":-0.403469,"twenty":-10.440328,"median":-7.776993,"eighty":-4.641331,"marketCap":25403239},{"date":"2021-12-23","current":-0.349342,"twenty":-10.440328,"median":-7.774654,"eighty":-4.551973,"marketCap":21995240},{"date":"2021-12-31","current":-0.324607,"twenty":-10.440328,"median":-7.773368,"eighty":-4.506123,"marketCap":20437877},{"date":"2022-01-07","current":-0.344688,"twenty":-10.420123,"median":-7.743987,"eighty":-4.398986,"marketCap":21702232},{"date":"2022-01-14","current":-0.305813,"twenty":-10.420123,"median":-7.697375,"eighty":-4.158987,"marketCap":19254614},{"date":"2022-01-21","current":-0.272813,"twenty":-10.401193,"median":-7.683917,"eighty":-3.998142,"marketCap":17176854},{"date":"2022-01-28","current":-0.269876,"twenty":-10.392703,"median":-7.662426,"eighty":-3.952187,"marketCap":16991923},{"date":"2022-02-04","current":-0.362657,"twenty":-10.377419,"median":-7.630738,"eighty":-3.924613,"marketCap":22833579},{"date":"2022-02-11","current":-0.300976,"twenty":-10.373833,"median":-7.58885,"eighty":-3.85568,"marketCap":18950021},{"date":"2022-02-18","current":-0.305986,"twenty":-10.372566,"median":-7.567828,"eighty":-3.832702,"marketCap":19265492},{"date":"2022-02-25","current":-0.313588,"twenty":-10.372249,"median":-7.567828,"eighty":-3.805129,"marketCap":19744138},{"date":"2022-03-04","current":-0.351426,"twenty":-10.357706,"median":-7.54109,"eighty":-3.699431,"marketCap":22126490},{"date":"2022-03-11","current":-0.341059,"twenty":-10.338052,"median":-7.488107,"eighty":-3.648879,"marketCap":21473788},{"date":"2022-03-18","current":-0.466495,"twenty":-10.317801,"median":-7.453716,"eighty":-3.56247,"marketCap":29371447},{"date":"2022-03-25","current":-0.498052,"twenty":-10.308727,"median":-7.407849,"eighty":-3.515608,"marketCap":31926138},{"date":"2022-04-01","current":-0.351701,"twenty":-10.308727,"median":-7.378472,"eighty":-3.49263,"marketCap":22544765},{"date":"2022-04-08","current":-0.406679,"twenty":-10.30349,"median":-7.361837,"eighty":-3.446348,"marketCap":26068921},{"date":"2022-04-14","current":-0.335036,"twenty":-10.299998,"median":-7.315567,"eighty":-3.412726,"marketCap":21476468},{"date":"2022-04-22","current":-0.33063,"twenty":-10.284223,"median":-7.289317,"eighty":-3.363954,"marketCap":21194045},{"date":"2022-04-29","current":-0.268182,"twenty":-10.256233,"median":-7.269814,"eighty":-3.304212,"marketCap":17190998},{"date":"2022-05-06","current":-0.237341,"twenty":-10.246454,"median":-7.255584,"eighty":-3.262852,"marketCap":15214031},{"date":"2022-05-13","current":-0.235042,"twenty":-10.241521,"median":-7.223051,"eighty":-3.193918,"marketCap":15066680},{"date":"2022-05-20","current":-0.296916,"twenty":-10.24085,"median":-7.17991,"eighty":-3.111198,"marketCap":17806915},{"date":"2022-05-27","current":-0.25719,"twenty":-10.232304,"median":-7.156784,"eighty":-2.807891,"marketCap":15424471},{"date":"2022-06-03","current":-0.254938,"twenty":-10.220993,"median":-7.123651,"eighty":-2.56001,"marketCap":15289384},{"date":"2022-06-10","current":-0.270295,"twenty":-10.218792,"median":-7.074537,"eighty":-2.527142,"marketCap":16210430},{"date":"2022-06-17","current":-0.247976,"twenty":-10.209773,"median":-7.035276,"eighty":-2.486971,"marketCap":14871843},{"date":"2022-06-24","current":-0.2748,"twenty":-10.208906,"median":-7.027217,"eighty":-2.465059,"marketCap":16480608},{"date":"2022-07-01","current":-0.141291,"twenty":-10.208906,"median":-6.99042,"eighty":-2.4468,"marketCap":8473627},{"date":"2022-07-08","current":-0.135148,"twenty":-10.208906,"median":-6.942455,"eighty":-2.384717,"marketCap":8105209},{"date":"2022-07-15","current":-0.139005,"twenty":-10.183482,"median":-6.920203,"eighty":-2.333589,"marketCap":8336548},{"date":"2022-07-22","current":-0.164655,"twenty":-10.169881,"median":-6.891825,"eighty":-2.227683,"marketCap":9874839},{"date":"2022-07-29","current":-0.134041,"twenty":-10.149254,"median":-6.874111,"eighty":-2.205772,"marketCap":8038814},{"date":"2022-08-05","current":-0.187822,"twenty":-10.14455,"median":-6.831467,"eighty":-2.187512,"marketCap":11264264},{"date":"2022-08-12","current":-0.18865,"twenty":-10.136005,"median":-6.792318,"eighty":-2.154644,"marketCap":11313886},{"date":"2022-08-19","current":-0.179188,"twenty":-10.133381,"median":-6.776236,"eighty":-2.136385,"marketCap":9528159},{"date":"2022-08-26","current":-0.167989,"twenty":-10.133259,"median":-6.706177,"eighty":-2.114473,"marketCap":8932649},{"date":"2022-09-02","current":-0.157723,"twenty":-10.133259,"median":-6.596341,"eighty":-2.099865,"marketCap":8386765},{"date":"2022-09-09","current":-0.165189,"twenty":-10.129645,"median":-6.560697,"eighty":-2.081606,"marketCap":8783771},{"date":"2022-09-16","current":-0.172655,"twenty":-10.12014,"median":-6.473437,"eighty":-2.056042,"marketCap":9180778},{"date":"2022-09-23","current":-0.143724,"twenty":-10.11541,"median":-6.458732,"eighty":-2.008567,"marketCap":7642377},{"date":"2022-09-30","current":-0.146524,"twenty":-10.107933,"median":-6.432654,"eighty":-1.739784,"marketCap":7791255},{"date":"2022-10-07","current":-0.158656,"twenty":-10.088275,"median":-6.419592,"eighty":-0.736212,"marketCap":8436391},{"date":"2022-10-14","current":-0.144657,"twenty":-10.078492,"median":-6.369589,"eighty":-0.655259,"marketCap":7692003},{"date":"2022-10-21","current":-0.130649,"twenty":-10.073049,"median":-6.338959,"eighty":-0.640788,"marketCap":6947119},{"date":"2022-10-28","current":-0.131591,"twenty":-10.058044,"median":-6.327545,"eighty":-0.603139,"marketCap":6997242},{"date":"2022-11-04","current":-0.121325,"twenty":-10.047522,"median":-6.306524,"eighty":-0.522681,"marketCap":6451357},{"date":"2022-11-11","current":-0.114833,"twenty":-10.029811,"median":-6.306524,"eighty":-0.464353,"marketCap":6106104},{"date":"2022-11-18","current":-0.162135,"twenty":-10.019309,"median":-6.269673,"eighty":-0.420504,"marketCap":5642798},{"date":"2022-11-25","current":-0.161194,"twenty":-10.018049,"median":-6.243458,"eighty":-0.404753,"marketCap":5610031},{"date":"2022-12-02","current":-0.140824,"twenty":-10.011558,"median":-6.242452,"eighty":-0.396065,"marketCap":4901082},{"date":"2022-12-09","current":-0.119826,"twenty":-10.004506,"median":-6.201415,"eighty":-0.386838,"marketCap":4170289},{"date":"2022-12-16","current":-0.101281,"twenty":-10.003231,"median":-6.19592,"eighty":-0.377863,"marketCap":3524887},{"date":"2022-12-23","current":-0.182591,"twenty":-10.001658,"median":-6.182446,"eighty":-0.36352,"marketCap":6354726},{"date":"2022-12-30","current":-0.164047,"twenty":-9.995465,"median":-6.169882,"eighty":-0.36177,"marketCap":5709324},{"date":"2023-01-06","current":-0.218254,"twenty":-9.970694,"median":-6.14886,"eighty":-0.357819,"marketCap":7595883},{"date":"2023-01-13","current":-0.186871,"twenty":-9.96774,"median":-6.13835,"eighty":-0.354236,"marketCap":6503665},{"date":"2023-01-20","current":-0.211121,"twenty":-9.96774,"median":-6.117328,"eighty":-0.350698,"marketCap":7347652},{"date":"2023-01-27","current":-0.199709,"twenty":-9.96774,"median":-6.096306,"eighty":-0.348895,"marketCap":6950482},{"date":"2023-02-03","current":-0.203989,"twenty":-9.959782,"median":-6.096306,"eighty":-0.344446,"marketCap":7099420},{"date":"2023-02-10","current":-0.192563,"twenty":-9.957792,"median":-6.096306,"eighty":-0.336843,"marketCap":6701754},{"date":"2023-02-17","current":-0.168868,"twenty":-9.957629,"median":-6.075284,"eighty":-0.330129,"marketCap":5877128},{"date":"2023-02-24","current":-0.27399,"twenty":-9.949534,"median":-6.064096,"eighty":-0.327118,"marketCap":9535678},{"date":"2023-03-03","current":-0.278797,"twenty":-9.936159,"median":-6.058032,"eighty":-0.318616,"marketCap":9702970},{"date":"2023-03-10","current":-0.257142,"twenty":-9.926163,"median":-5.996865,"eighty":-0.312272,"marketCap":8949317},{"date":"2023-03-17","current":-0.242746,"twenty":-9.923057,"median":-5.994031,"eighty":-0.307069,"marketCap":8448276},{"date":"2023-03-24","current":-0.228325,"twenty":-9.920692,"median":-5.954828,"eighty":-0.303878,"marketCap":7946398},{"date":"2023-03-31","current":-2.822389,"twenty":-9.904086,"median":-5.8966,"eighty":-0.305917,"marketCap":7287408},{"date":"2023-04-06","current":-3.305209,"twenty":-9.894067,"median":-5.886089,"eighty":-0.306055,"marketCap":8534049},{"date":"2023-04-14","current":-3.597169,"twenty":-9.894002,"median":-5.886089,"eighty":-0.306505,"marketCap":9287890},{"date":"2023-04-21","current":-3.240401,"twenty":-9.893331,"median":-5.878633,"eighty":-0.307053,"marketCap":8366715},{"date":"2023-04-28","current":-2.916361,"twenty":-9.887196,"median":-5.838007,"eighty":-0.307552,"marketCap":7530043},{"date":"2023-05-05","current":-3.402421,"twenty":-9.875595,"median":-5.798664,"eighty":-0.309476,"marketCap":8785050},{"date":"2023-05-12","current":-3.272805,"twenty":-9.859623,"median":-5.758673,"eighty":-0.311618,"marketCap":8450382},{"date":"2023-05-19","current":-3.175593,"twenty":-9.842937,"median":-5.758626,"eighty":-0.312193,"marketCap":8199380},{"date":"2023-05-26","current":-2.75434,"twenty":-9.820069,"median":-5.719653,"eighty":-0.312272,"marketCap":7111707},{"date":"2023-06-02","current":-2.841507,"twenty":-9.778989,"median":-5.698687,"eighty":-0.312272,"marketCap":7336772},{"date":"2023-06-09","current":-3.045977,"twenty":-9.73735,"median":-5.661783,"eighty":-0.312272,"marketCap":7864712},{"date":"2023-06-16","current":-3.726461,"twenty":-9.708781,"median":-5.599721,"eighty":-0.312272,"marketCap":9621722},{"date":"2023-06-23","current":-3.953289,"twenty":-9.628704,"median":-5.59871,"eighty":-0.312193,"marketCap":10207392},{"date":"2023-06-30","current":-4.679787,"twenty":-9.571866,"median":-5.59871,"eighty":-0.312113,"marketCap":12083209},{"date":"2023-07-07","current":-3.726461,"twenty":-9.517345,"median":-5.59871,"eighty":-0.312113,"marketCap":9621722},{"date":"2023-07-14","current":-4.082905,"twenty":-9.428678,"median":-5.541532,"eighty":-0.312113,"marketCap":10542060},{"date":"2023-07-21","current":7.191013,"twenty":-9.389383,"median":-5.500121,"eighty":-0.306332,"marketCap":9772586},{"date":"2023-07-28","current":6.809189,"twenty":-9.338627,"median":-5.439746,"eighty":-0.297796,"marketCap":9253688},{"date":"2023-08-04","current":6.03345,"twenty":-9.303224,"median":-5.323829,"eighty":-0.288977,"marketCap":8199459},{"date":"2023-08-11","current":5.466442,"twenty":-9.248308,"median":-5.258788,"eighty":-0.283332,"marketCap":7428895},{"date":"2023-08-18","current":2.314022,"twenty":-9.212921,"median":-5.198802,"eighty":-0.280575,"marketCap":7092476},{"date":"2023-08-25","current":2.354371,"twenty":-9.171234,"median":-5.078829,"eighty":-0.275321,"marketCap":7216147},{"date":"2023-09-01","current":2.567686,"twenty":-9.133155,"median":-4.958857,"eighty":-0.273048,"marketCap":7869959},{"date":"2023-09-08","current":2.342238,"twenty":-9.116111,"median":-4.908214,"eighty":-0.271009,"marketCap":7178959},{"date":"2023-09-15","current":2.418986,"twenty":-9.056313,"median":-4.799362,"eighty":-0.268022,"marketCap":7414193},{"date":"2023-09-22","current":2.116225,"twenty":-9.01825,"median":-4.67179,"eighty":-0.259156,"marketCap":6486230},{"date":"2023-09-29","current":2.031576,"twenty":-8.977038,"median":-4.650929,"eighty":-0.257477,"marketCap":6226781},{"date":"2023-10-06","current":1.946927,"twenty":-8.926227,"median":-4.628933,"eighty":-0.254798,"marketCap":5967331},{"date":"2023-10-13","current":2.114811,"twenty":-8.90578,"median":-4.506123,"eighty":-0.248795,"marketCap":6481897},{"date":"2023-10-20","current":1.936205,"twenty":-8.869724,"median":-4.386288,"eighty":-0.244904,"marketCap":5934468},{"date":"2023-10-27","current":1.644448,"twenty":-8.860213,"median":-4.158987,"eighty":-0.241628,"marketCap":5040233},{"date":"2023-11-03","current":1.807256,"twenty":-8.822859,"median":-4.018097,"eighty":-0.236099,"marketCap":5539240},{"date":"2023-11-10","current":1.69298,"twenty":-8.803345,"median":-3.98148,"eighty":-0.230993,"marketCap":5188984},{"date":"2023-11-17","current":1.594223,"twenty":-8.803345,"median":-3.952187,"eighty":-0.218303,"marketCap":4886293},{"date":"2023-11-24","current":1.411099,"twenty":-8.803345,"median":-3.929209,"eighty":-0.211692,"marketCap":4325018},{"date":"2023-12-01","current":1.300773,"twenty":-8.788193,"median":-3.837298,"eighty":-0.207419,"marketCap":3986869},{"date":"2023-12-08","current":1.13514,"twenty":-8.788193,"median":-3.81432,"eighty":-0.203844,"marketCap":3479205},{"date":"2023-12-15","current":1.636547,"twenty":-8.788193,"median":-3.777588,"eighty":-0.201136,"marketCap":5016018},{"date":"2023-12-22","current":1.630904,"twenty":-8.788193,"median":-3.724435,"eighty":-0.198585,"marketCap":4998721},{"date":"2023-12-29","current":1.665046,"twenty":-8.788193,"median":-3.699147,"eighty":-0.196,"marketCap":5103365},{"date":"2024-01-05","current":1.681129,"twenty":-8.788193,"median":-3.669053,"eighty":-0.19335,"marketCap":5152661},{"date":"2024-01-12","current":2.144441,"twenty":-8.788193,"median":-3.595711,"eighty":-0.190473,"marketCap":6572713},{"date":"2024-01-19","current":1.70991,"twenty":-8.788193,"median":-3.564441,"eighty":-0.189207,"marketCap":5240874},{"date":"2024-01-26","current":1.503931,"twenty":-8.788193,"median":-3.535311,"eighty":-0.186697,"marketCap":4609547},{"date":"2024-02-02","current":1.523259,"twenty":-8.788193,"median":-3.505879,"eighty":-0.182109,"marketCap":4668788},{"date":"2024-02-09","current":1.664764,"twenty":-8.788193,"median":-3.496132,"eighty":-0.179188,"marketCap":5102501},{"date":"2024-02-16","current":1.721196,"twenty":-8.788193,"median":-3.458163,"eighty":-0.172842,"marketCap":5275467},{"date":"2024-02-23","current":1.672382,"twenty":-8.788193,"median":-3.434825,"eighty":-0.170867,"marketCap":5125851},{"date":"2024-03-01","current":2.003642,"twenty":-8.788193,"median":-3.412726,"eighty":-0.167989,"marketCap":6141162},{"date":"2024-03-08","current":1.834062,"twenty":-8.788193,"median":-3.354763,"eighty":-0.166546,"marketCap":5621399},{"date":"2024-03-15","current":1.724018,"twenty":-8.788193,"median":-3.331785,"eighty":-0.165189,"marketCap":5284115},{"date":"2024-03-22","current":1.757878,"twenty":-8.788193,"median":-3.28583,"eighty":-0.163613,"marketCap":5387895},{"date":"2024-03-28","current":1.742641,"twenty":-8.788193,"median":-3.262852,"eighty":-0.161194,"marketCap":5341194},{"date":"2024-04-05","current":1.580115,"twenty":-8.788193,"median":-3.201119,"eighty":-0.15869,"marketCap":4843051},{"date":"2024-04-12","current":1.658556,"twenty":-8.788193,"median":-3.171646,"eighty":-0.157723,"marketCap":5083474},{"date":"2024-04-19","current":1.633162,"twenty":-8.788193,"median":-3.124985,"eighty":-0.149697,"marketCap":5005640},{"date":"2024-04-26","current":1.436211,"twenty":-8.788193,"median":-3.045977,"eighty":-0.146888,"marketCap":4401988},{"date":"2024-05-03","current":1.413638,"twenty":-8.788193,"median":-2.965939,"eighty":-0.144308,"marketCap":4332801},{"date":"2024-05-10","current":1.30825,"twenty":-8.788193,"median":-2.916361,"eighty":-0.142706,"marketCap":4009787},{"date":"2024-05-17","current":1.464428,"twenty":-8.788193,"median":-2.841507,"eighty":-0.140259,"marketCap":4488471},{"date":"2024-05-24","current":1.304965,"twenty":-8.788193,"median":-2.773783,"eighty":-0.137561,"marketCap":3874441},{"date":"2024-05-31","current":1.022417,"twenty":-8.788193,"median":-2.711384,"eighty":-0.135694,"marketCap":3035555},{"date":"2024-06-07","current":1.379243,"twenty":-8.788193,"median":-2.556358,"eighty":-0.131965,"marketCap":4094973},{"date":"2024-06-14","current":-0.171448,"twenty":-8.788193,"median":-2.510708,"eighty":-0.131778,"marketCap":2899864},{"date":"2024-06-21","current":-0.21177,"twenty":-8.788193,"median":-2.483319,"eighty":-0.131591,"marketCap":2824167},{"date":"2024-06-28","current":-0.196169,"twenty":-8.803345,"median":-2.455929,"eighty":-0.131591,"marketCap":2616107},{"date":"2024-07-05","current":-0.204472,"twenty":-8.803345,"median":-2.42854,"eighty":-0.131591,"marketCap":2726841},{"date":"2024-07-12","current":-0.212841,"twenty":-8.803345,"median":-2.337241,"eighty":-0.131591,"marketCap":2838441},{"date":"2024-07-15","current":-0.214268,"twenty":-8.803345,"median":-2.328112,"eighty":-0.131591,"marketCap":2857474},{"date":"2024-08-02","current":-0.321045,"twenty":-8.838158,"median":-2.209424,"eighty":-0.130656,"marketCap":4281453},{"date":"2024-08-09","current":-0.352961,"twenty":-8.793244,"median":-2.172904,"eighty":-0.130656,"marketCap":4707089},{"date":"2024-08-16","current":-0.383333,"twenty":-8.748588,"median":-2.154644,"eighty":-0.130656,"marketCap":3132600},{"date":"2024-08-23","current":-0.414457,"twenty":-8.712543,"median":-2.118125,"eighty":-0.130656,"marketCap":3386946},{"date":"2024-08-30","current":-0.395931,"twenty":-8.696534,"median":-2.099865,"eighty":-0.130656,"marketCap":3235548},{"date":"2024-09-06","current":-0.395931,"twenty":-8.69617,"median":-2.081606,"eighty":-0.130656,"marketCap":3235548},{"date":"2024-09-13","current":-0.323944,"twenty":-8.675625,"median":-2.026827,"eighty":-0.130656,"marketCap":2647267},{"date":"2024-09-20","current":-0.83209,"twenty":-8.561467,"median":-1.953788,"eighty":-0.130656,"marketCap":6799843},{"date":"2024-09-27","current":-0.806683,"twenty":-8.484698,"median":-0.895609,"eighty":-0.130656,"marketCap":6592214},{"date":"2024-10-04","current":-0.586486,"twenty":-8.359171,"median":-0.774924,"eighty":-0.130656,"marketCap":4792764},{"date":"2024-10-11","current":-0.576492,"twenty":-8.193627,"median":-0.665085,"eighty":-0.130656,"marketCap":4711090},{"date":"2024-10-18","current":-0.652759,"twenty":-8.096203,"median":-0.652759,"eighty":-0.130656,"marketCap":5334347},{"date":"2024-10-25","current":-0.522656,"twenty":-8.004225,"median":-0.640452,"eighty":-0.130656,"marketCap":4271143},{"date":"2024-10-31","current":-0.587707,"twenty":-7.976555,"median":-0.608961,"eighty":-0.130656,"marketCap":4802745},{"date":"2024-11-08","current":-0.578735,"twenty":-7.890145,"median":-0.601166,"eighty":-0.130654,"marketCap":4729421},{"date":"2024-11-15","current":-0.713324,"twenty":-7.774397,"median":-0.601166,"eighty":-0.130654,"marketCap":5829286},{"date":"2024-11-22","current":-4.968196,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":19907563},{"date":"2024-11-29","current":-19.17664,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":76840795},{"date":"2024-12-06","current":-14.924092,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":59800837},{"date":"2024-12-13","current":-11.380027,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":45599767},{"date":"2024-12-20","current":-10.235521,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":41013733},{"date":"2024-12-27","current":-11.217455,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":44948342},{"date":"2025-01-03","current":-9.87136,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":39554541},{"date":"2025-01-10","current":-6.818294,"twenty":-7.683917,"median":-0.601166,"eighty":-0.130653,"marketCap":27320906},{"date":"2025-01-17","current":-6.742451,"twenty":-7.522773,"median":-0.601166,"eighty":-0.130653,"marketCap":27017003},{"date":"2025-01-24","current":-10.360167,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":41513190},{"date":"2025-01-31","current":-8.198639,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":32851946},{"date":"2025-02-07","current":-8.721956,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":34948879},{"date":"2025-02-14","current":-7.652569,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":30663842},{"date":"2025-02-21","current":-6.401157,"twenty":-7.397163,"median":-0.601166,"eighty":-0.130653,"marketCap":25649438},{"date":"2025-02-28","current":-5.77166,"twenty":-7.335924,"median":-0.601166,"eighty":-0.130653,"marketCap":23127041},{"date":"2025-03-07","current":-8.661282,"twenty":-7.361837,"median":-0.597786,"eighty":-0.130651,"marketCap":34705756},{"date":"2025-03-14","current":-10.026458,"twenty":-7.454477,"median":-0.597786,"eighty":-0.130651,"marketCap":40176016},{"date":"2025-03-21","current":-4.247942,"twenty":-7.546287,"median":-0.597786,"eighty":-0.130651,"marketCap":41209287},{"date":"2025-03-28","current":-9.117492,"twenty":-7.626003,"median":-0.597786,"eighty":-0.130651,"marketCap":88448794},{"date":"2025-04-04","current":-8.61603,"twenty":-7.697375,"median":-0.597786,"eighty":-0.130651,"marketCap":83584110},{"date":"2025-04-11","current":-7.359119,"twenty":-7.741051,"median":-0.601166,"eighty":-0.130653,"marketCap":71390812},{"date":"2025-04-17","current":-7.521931,"twenty":-7.741051,"median":-0.601166,"eighty":-0.130653,"marketCap":72970255},{"date":"2025-04-25","current":-7.251663,"twenty":-7.742316,"median":-0.597786,"eighty":-0.130651,"marketCap":70348380},{"date":"2025-05-02","current":-6.492957,"twenty":-7.742316,"median":-0.597786,"eighty":-0.130651,"marketCap":62988176},{"date":"2025-05-09","current":-7.411219,"twenty":-7.694683,"median":-0.597786,"eighty":-0.130651,"marketCap":71896233}],"updateTime":1747056611072}}}